Crohn's Disease European Registry. A Prospective, Observational, Postmarketing Safety Surveillance Registry of Patients Treated With Remicade or Standard Therapy
Phase of Trial: Phase IV
Latest Information Update: 21 Oct 2014
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- Acronyms ENCORE
- Sponsors Merck & Co; Schering-Plough
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2012 Company added in association field as reported by ClinicalTrials.gov.
- 10 Oct 2009 New trial record.